Tachi Yamada, long-serving polio advocate at Gates Foundation, steps down as President of Global Health Program

Dr Tachi Yamada has stepped down from his position as President of the Global Health Program at the Bill & Melinda Gates Foundation.

Dr. Tachi Yamada
Dr. Tachi Yamada Bill & Melinda Gates Foundation

Dr Tachi Yamada has stepped down from his position as President of the Global Health Program at the Bill & Melinda Gates Foundation on 17 June 2011. For the past five years, Dr Yamada led the Foundation’s efforts to help develop and deliver low-cost, life-saving health tools for the developing world.

In his role, Dr Yamada has been instrumental in scaling up the Foundation’s support to the Global Polio Eradication Initiative (GPEI) especially at the critical juncture in the programme as it researched, prepared and rolled out the new Strategic Plan 2010- 2012 which has led to the striking achievements of the past 12 months. In addition to supporting the development and/or scaling up of important new tools and tactics, such as the new bivalent oral polio vaccine, Yamada personally advocated with leaders of both polio-infected and donor countries to help secure support for a polio-free world.

“Tachi Yamada’s leadership and personal engagement in polio eradication has made a huge difference to the programme,” said Dr Bruce Aylward, Assistant Director-General for Polio Eradication at the World Health Organization (WHO). “His drive and vision helped elevate polio eradication to the new level of attention it now has with leaders everywhere – ultimately this is what will secure a polio-free world. The entire GPEI wishes Tachi the very best for his future endeavours, which we are sure will include continued advocacy for the protection of children everywhere from this terrible disease, forever.”


Related News

   14/09/2021
Update on polio eradication efforts in Pakistan for August 2021
   14/09/2021
GPEI joins the 5-year action journey to achieve irreversible progress towards gender equality
   27/08/2021
Three polio survivors from Mozambique, Congo and Ethiopia share their experiences of living with the effects of disease, and their hope for a polio-free world.
   27/08/2021
Learn how the type 2 novel oral polio vaccine (nOPV2) is being rolled out across Africa to help more sustainably address outbreaks of a non-wild form of polio, cVDPV2, and protect children across the continent.
   27/08/2021
Despite success against wild polio in the African region, outbreaks of the non-wild form of polio, cVDPV2, continue. With continued country commitment to eradication, a future where no child in Africa is paralysed by the virus is possible.